Structures by: Forbes R. P.

Total: 11

Tris(<i>tert</i>-butyl isocyanide)bis[tris(4-methoxyphenyl)phosphine]cobalt(II) bis(perchlorate) dichloromethane disolvate

C57H69CoN3O6P22,2(ClO4),2(CH2Cl2)

Becker, Clifford A. L.Black, Robert S.Forbes, Roy P.

Acta Crystallographica Section C (2010) 66, 2 m40-m43

a=12.3461(3)Å   b=19.7566(5)Å   c=28.4452(7)Å

α=90°   β=92.818(2)°   γ=90°

Tris(<i>tert</i>-butyl isocyanide)bis[tris(4-methoxyphenyl)phosphine]cobalt(I) perchlorate dichloromethane disolvate

C57H69CoN3O6P2,ClO4,2(CH2Cl2)

Becker, Clifford A. L.Black, Robert S.Forbes, Roy P.

Acta Crystallographica Section C (2010) 66, 2 m40-m43

a=21.7568(3)Å   b=21.7568(3)Å   c=23.3983(6)Å

α=90°   β=90°   γ=120°

Diaquatetrakis(<i>tert</i>-butyl isocyanide)cobalt(II) bis(perchlorate)

C20H40CoN4O22,2ClO4

Becker, Clifford A. L.Forbes, Roy P.Black, Robert S.

Acta Crystallographica Section C (2009) 65, 8 m302-m304

a=15.8300(10)Å   b=8.1176(5)Å   c=13.8319(9)Å

α=90°   β=122.0130(10)°   γ=90°

(N'-(diphenylmethylene)isonicotinohydrazide)_(salicylic acid)

C19H15N3O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=25.8071(6)Å   b=6.9240(2)Å   c=12.2426(3)Å

α=90°   β=103.5010(10)°   γ=90°

(N'-(bis(2-hydroxyphenyl)methylene)isonicotinohydrazide)_(salicyclic acid)

C19H15N3O3,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=25.010(2)Å   b=6.9708(7)Å   c=12.4779(11)Å

α=90°   β=90.949(6)°   γ=90°

(N'-(di-p-tolylmethylene)isonicotinohydrazide)_(salicyclic acid) Form I

C21H19N3O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=9.9062(2)Å   b=12.0906(3)Å   c=12.4633(3)Å

α=113.5360(10)°   β=113.0770(10)°   γ=96.2970(10)°

(N'-(di-p-tolylmethylene)isonicotinohydrazide)_(salicylic acid) Form II

C21H19N3O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=8.2520(3)Å   b=11.2852(4)Å   c=12.9411(5)Å

α=77.516(2)°   β=85.880(2)°   γ=82.910(2)°

(E)-N'-((4-aminophenyl)(phenyl)methylene)isonicotinohydrazide)_(salicylic acid)

C19H16N4O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=7.8452(3)Å   b=10.7034(4)Å   c=13.1775(5)Å

α=90°   β=93.234(3)°   γ=90°

((E)-N'-(phenyl(p-tolyl)methylene)isonicotinohydrazide)_(salicyclic acid),

C20H17N3O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=6.6193(2)Å   b=12.3234(3)Å   c=14.4180(3)Å

α=98.727(2)°   β=98.596(2)°   γ=100.665(2)°

(E)-N'-((4-aminophenyl)(phenyl)methylene)isonicotinohydrazide)_(salicylic acid)

C19H16N4O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=9.2815(3)Å   b=11.7198(3)Å   c=12.2187(3)Å

α=94.4050(10)°   β=110.971(2)°   γ=113.076(2)°

((E)-N'-((4-(dimethylamino)phenyl)(phenyl)methylene)isonicotinohydrazide)_ (salicylic acid)

C21H20N4O,C7H6O3

Smith, Mark G.Forbes, Roy P.Lemmerer, Andreas

Crystal Growth & Design (2015) 15, 8 3813

a=7.0057(4)Å   b=11.5495(7)Å   c=15.6046(9)Å

α=87.598(4)°   β=82.792(4)°   γ=72.850(3)°